Back to search
FDAFDA · Food and drugs·Recall number D-0804-2026

Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-4379-3

Published September 2, 2026 · Recall initiated: August 13, 2026

Summary

FDA records drug Class II recall D-0804-2026, published September 2, 2026 and initiated August 13, 2026. Recalling firm: Apotex Corp.; Status: Ongoing; Reported quantity: 6,972 bottles; Lot: Lot # TY9494, Exp Date: 05/31/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria

What to do

Voluntary: Firm initiated · Letter

Get an email if PAXIL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PAXIL
Manufacturer
Apotex Corp.
Distributor
US Nationwide.
UPC
0360505366835
Lot
Lot # TY9494, Exp Date: 05/31/2027.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-4379-3 recalled?

Yes. FDA published recall D-0804-2026 on September 2, 2026. Reported hazard: Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PAXIL. UPC: 0360505366835.